Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs

NYSE:CLX

Clorox Company (CLX)

107.17
+0.48 (0.45%)
as of Aug 24, 2026, 8:00:00 pm Market Open.
78 watching
0
Investor Insights
star iconAug 24, 2026, 12:00 am

This summary was created by AI, based on 4 opinions in the last 12 months.

Clorox Company (CLX) has garnered mixed reviews from various experts. Many highlight its status as a dividend aristocrat, boasting a solid 5% dividend yield while trading at a lower-than-historical P/E ratio, suggesting potential value. However, the company has faced significant challenges, including a -11.83% decline this year and a sharp 30% drop amid economic fluctuations and inflation concerns. The market dynamics have shifted; previously favored consumer packaged goods are now being scrutinized, particularly as consumers may shy away from name brands. Experts note that despite recent struggles, Clorox's earnings growth is stabilizing, and the long history of dividend increases presents a promising outlook, especially in a volatile market influenced by oil prices.

consensus icon
Consensus
Mixed
valuation icon
Valuation
Undervalued
review icon
Similar
Procter&Gamble,PG
DON'T BUY

The Fair Market Value is 41% below the current price. It is currently trading at the Price to Book of 25X. This stock is simply not investment grade anymore.

HOLD

In a higher interest rate environment, you are starting to see opportunities for different kinds of returns. This is a very safe stock and grows slowly. Increases its dividend regularity. At this price, it is a little rich.

COMMENT

This has done well and they’ve had some positive earnings revisions. In the “staples” category it has a few things going right for it. It is a higher payor, so you get a nice dividend. Earnings growth should be in the high to mid single digits. The catch is, any valuation is quite rich. It’s come off a little since the peak, but staples, as a whole, is trading expensive. Interest rates going higher will put pressure on the stock.

BUY
You can’t go wrong. Canadian market has moved but US has not moved yet.
BUY
Has been performing quite well recently because of some improving revenue lines. Expects next year, 2nd quarter, to grow their revenues by 30%. P/E multiple is about 20 X, so not expensive. Should be a good solid performer.
TOP PICK
May be the subject of some corporate restructuring. Good consumer company.
Showing 31 to 36 of 36 entries